University of Leeds M.Sc Cancer Biology and Therapy Application Deadline, Eligibility Requirements, Fees and Scholarships, etc.

University of Leeds Cancer Biology and Therapy Master of Science (MSc) is a 12-month, full-time, on-campus postgraduate pathway in Leeds for September entry. The course requires a relevant United Kingdom (UK) 2:1 equivalent, which Leeds maps to a first-class Indian bachelor’s result at 60%.

September 2027 tuition is unpublished; September 2026 tuition was £32,000 (INR 41.44 Lakhs), as a prior-cycle reference for budgeting. The pathway examines molecular mechanisms of cancer, therapeutic development and translational research through taught modules, laboratory or analytical work and a major research project. It suits biomedical, medical or biological science graduates seeking a Doctor of Philosophy (PhD), research or cancer-drug-development route. For wider postgraduate context, review the University of Leeds postgraduate study overview before selecting the pathway.

• A four-month individual research project can produce evidence for doctoral or industry applications.
• The pathway combines molecular cancer biology with cancer drug development, stem cell biology and disease models.
• Research opportunities span laboratories at Leeds Institute of Medical Research at St James’s and the main University campus.

Also Check: University of Leeds admission overview

Leeds Cancer Biology and Therapy Fees and Living Costs 2027

September 2027 tuition remains unpublished after checks of the live pathway page and Leeds Masters fee guidance. The prior-cycle figure below supports planning, but it does not establish the target charge.

September 2026 prior-cycle context: Leeds listed the international tuition for the full-time pathway as a total course fee. No target-cycle deposit or application fee is added because those details are not published for September 2027.

All INR conversions in the article use a conversion rate of GBP 1 = INR 129.50 as of 07 August 2026. Rates fluctuate daily, verify before applying.

Source: University of Leeds Molecular Medicine MSc page and Masters fees guidance.

The prior-cycle tuition is a substantial upfront commitment because the course lasts one academic year. Indian applicants using loans should keep separate liquidity for living costs, visa charges and the period before any scholarship is confirmed.

Cost of Living in Leeds for Cancer Biology and Therapy Students

Leeds estimates a single student’s 2025 costs at £199 to £423 weekly (INR 25,771 to INR 54,779). The official annual range is £10,348 to £21,996 (INR 13.40 Lakhs to INR 28.48 Lakhs), while the monthly figures below are calculated from the weekly range.

The prior-cycle planning illustration adds £32,000 (INR 41.44 Lakhs) tuition to £10,348 to £21,996 (INR 13.40 Lakhs to INR 28.48 Lakhs) living costs. That produces £42,348 to £53,996 (INR 54.84 Lakhs to INR 69.92 Lakhs) before flights, visa charges and personal purchases.

Key insight: The prior-cycle academic and living illustration reaches INR 69.92 Lakhs before visa and travel. Indian applicants should wait for the 2027 fee before fixing a loan amount.

Leeds Cancer Biology and Therapy Admission 2027

The programme requires a UK 2:1 honours degree or equivalent in biomedicine, medicine, biological sciences or possibly natural sciences. For Indian applicants, Leeds maps a 2:1 to a first-class bachelor’s result at 60%.

Leeds also lists typical postgraduate country ranges of 60% to 85% overall and 75% to 90% in two relevant subjects. The current course page presents Cancer Biology and Therapy within the Molecular Medicine MSc listing, so pathway selection remains important.

The 60% country equivalence is a threshold, not a promise of admission, because the pathway still expects relevant scientific preparation. Show the modules that support cancer biology, laboratory work, statistics or bioinformatics in your transcript and statement.

The course is structurally different from a taught-only cancer survey because it allocates about four months to an individual laboratory or analytical research project. That design favors applicants with project records and creates a tradeoff for students seeking a short classroom-only qualification.

English Language Proficiency Requirements

Leeds requires IELTS (International English Language Testing System) Academic or UKVI (UK Visas and Immigration) at 6.5 overall with no less than 6.0 in each component. This requirement matches the current pathway page and the 2026/27 programme catalogue.

The current policy also gives a post-21 January 2026 TOEFL scale, so Indian applicants should select a test by its published version rather than convert scores. The change matters because the old and new TOEFL scales are not interchangeable in the table.

Most listed results must be no more than two years old at the course start, and Leeds does not accept TOEFL MyBest or the TOEFL iBT Paper Edition. Applicants below the direct score can investigate a Leeds postgraduate pre-sessional route, but its visa and score rules are separate.

• Book IELTS or PTE early enough to preserve a retake before offer conditions become due.
• Use the exact post-2026 TOEFL 4.5 scale and component minima when ordering a score report.
• Indian Standard XII English holders should confirm their board threshold before relying on a school result instead of a test.

Tip for Indian students: A 60% degree can meet the published country conversion, while course-linked evidence must show readiness for laboratory and analytical assessment.

Leeds Cancer Biology and Therapy Application 2027

The programme lists a September intake, and the September 2027 application is not yet open. Leeds published a 31 July 2026 international deadline for the previous annual cycle, so the target date is expected as 31 July 2027.

No 2027 decision date or application opening date was published after checking the current course page, postgraduate application guidance and 2026/27 catalogue. The table keeps only forward-looking target-cycle timing and marks the deadline Expected.

The current listing presents Cancer Biology and Therapy inside Molecular Medicine MSc, so the application should name the pathway rather than a different course option. A complete file needs one reference, a curriculum vitae (CV), a degree certificate and an official transcript.

Recent graduates should provide an academic referee from a biomedical sciences perspective, while applicants with relevant experience should use an industry reference. The transcript must show the modules and marks that support the proposed cancer research direction.

Leeds says applications are assessed through qualifications and experience, and the course may close when accepted numbers reach capacity. Use the statement to connect one laboratory, computational or analytical project with the cancer question you want to pursue.

• Upload an official or interim transcript so the admissions team can assess your scientific preparation.
• Describe your individual contribution to each research project instead of listing techniques without results.
• Submit before the expected deadline because the course may close when accepted numbers reach capacity.

Application tip: A focused file should join relevant scientific preparation, one research example and the Cancer Biology and Therapy pathway instead of presenting broad interest in cancer.

Leeds Cancer Biology and Therapy Scholarships 2027

Leeds has not published 2027-28 scholarship values or deadlines for this pathway. The prior 2026-27 schemes below show possible funding mechanics, but none should be treated as confirmed target-cycle support.

The awards differ in how they reduce risk: one is automatic for eligible Indian passport holders, one is merit-based and the alumni discount requires prior Leeds study. A 2027 applicant should calculate gross tuition first because awards may be non-deferrable.

Prior 2026-27 scholarship context: values and eligibility below come from Leeds pages for September 2026 or current published alumni terms, so target-cycle rechecking remains necessary.

The regional award is especially relevant for Indian applicants because India is explicitly listed among eligible passports. The excellence award uses a separate application route, while the alumni discount is unavailable without a Leeds study history.

The prior maximum of £16,000 (INR 20.72 Lakhs) should not be subtracted from unpublished 2027 tuition. It is only an upside scenario until the new terms and pathway eligibility are confirmed.

The Business School Global Community Bursary is restricted to Business School Masters programmes, so it is not a course-eligible award here. This distinction prevents applicants from treating an unrelated award as Cancer Biology and Therapy funding.

• Apply for the automatic regional award only after confirming that the 2027 course remains eligible and the award still lists India.
• Prepare a concise academic and professional evidence file for the excellence application before its target deadline appears.
• Leeds alumni should check the discount’s self-funding rule before combining it with another award.

Also Check: University of Leeds scholarships

Scholarship reality: Prior awards could reduce borrowing, but no 2027 support is confirmed, so build a gross-cost plan before treating funding as available.

Leeds Cancer Biology and Therapy Salary 2027

Leeds does not publish a course-level salary, offer rate or placement rate for Cancer Biology and Therapy. The official career evidence lists PhD students, medical writers, industry research scientists, academic research assistants and National Health Service (NHS) healthcare technicians or scientists.

Because outcomes are research-oriented, the useful comparison is pathway evidence plus an external occupation benchmark. The benchmark below is not a graduate salary and cannot predict an individual first offer.

Source: University of Leeds Molecular Medicine MSc career evidence and the National Careers Service pharmacologist profile.

The £27,000 to £55,000 (INR 34.97 Lakhs to INR 71.23 Lakhs) range describes the pharmacologist occupation, not Leeds graduates. Take-home pay changes with tax, pension and location, so use a current UK tax calculator after receiving an offer.

Return on Investment (ROI) for Indian Research Applicants

The prior-cycle cost illustration is £42,348 to £53,996 (INR 54.84 Lakhs to INR 69.92 Lakhs), while 2027 tuition and course salary outcomes remain unpublished.

The course’s value is therefore research access and portfolio evidence, not a verified payback period. This makes the intended next role more important than a broad salary comparison.

• The four-month individual laboratory or analytical project can support doctoral or industry applications, so preserve protocols, data interpretation and your personal contribution.
• Leeds lists PhD and research-scientist pathways but no offer rate, so do not build loan repayment on a guaranteed UK job.
• The prior-cycle tuition alone was £32,000 (INR 41.44 Lakhs), so set a borrowing ceiling before any scholarship is confirmed.
• The Graduate Route lasts 18 months for a Masters graduate, so identify sponsor-eligible research or clinical roles before the visa window begins.
• India-return applicants should test the same research portfolio against local pharmaceutical, diagnostics and academic roles because UK benchmarks do not transfer directly.

This course is financially strongest when the research project is essential to a doctoral or drug-development transition. It is harder to justify when the sole aim is a generic biomedical credential without a defined next role.

ROI reality: The course offers research evidence and documented career paths, but missing cohort salary data makes funding discipline more important than optimistic payback assumptions.

UK Visa for Leeds Cancer Biology and Therapy Students 2027

Indian students need a UK Student visa, which costs £558 (INR 72,261), plus the Immigration Health Surcharge of £776 (INR 1.00 Lakhs) per charged year. Leeds is outside London, so the cached maintenance requirement is £9,207 for nine months (INR 11.92 Lakhs). This maintenance test is separate from the university’s Leeds living-cost estimate.

Indefinite Leave to Remain (ILR) is the permanent settlement status. The usual qualifying period is five years, while Graduate Route time does not count toward the Skilled Worker route.

• The Graduate Route provides 18 months after a Masters, so use the period to obtain a sponsored role rather than treating it as permanent status.
• The standard Skilled Worker salary threshold is £41,700 (INR 54.00 Lakhs), although occupation codes and new-entrant rules can change the applicable figure.
• A Student visa permits up to 20 hours of work per week during term time for eligible full-time degree study, but part-time income should not replace funding evidence.
• Taught postgraduate students generally cannot bring dependants, although government-sponsored exceptions may apply.

Check Out: United Kingdom student visa overview

Visa reality: An 18-month Graduate Route and a five-year settlement pathway create different clocks, so Indian applicants should map sponsorship before relying on UK-based repayment.

Leeds Cancer Biology and Therapy Ranking 2027

The MSc is not separately ranked. The closest current discipline context is Leeds’s joint 93rd worldwide position in Life Sciences and Medicine in the QS (Quacquarelli Symonds) World University Rankings by Subject 2026.

This is a broad subject result rather than a course outcome, so it supports the research setting but does not establish salary, admission selectivity or laboratory quality for this pathway.

Ranking context for September 2027: the edition below is the latest official subject result checked for the research discipline linked to this pathway.

The position is most useful when paired with the pathway’s four-month research project and cancer-focused modules. Applicants should still check whether available supervisors and project themes match their intended cancer mechanism or therapeutic area.

Also Check: University of Leeds ranking details

Honest take: The broad subject position supports academic visibility, but project fit and supervisor alignment are more useful decisions for this research pathway.